Phibro Animal Health | PAHC - Ebit

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $26M in EBIT for its fiscal quarter ending in September of 2024.





Ebit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Henry Schein USD 198M 2.25B Sep/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Pacira USD 13.15M 2.92M Sep/2025
Phibro Animal Health USD 26M 5.54M Sep/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Zoetis USD 835M 140M Dec/2025